Trimorphs of a pharmaceutical cocrystal involving two active pharmaceutical ingredients: potential relevance to combination drugs

被引：140

作者：

Aitipamula, Srinivasulu ^{[1
]}

Chow, Pui Shan ^{[1
]}

Tan, Reginald B. H. ^{[1
,2
]}

机构：

[1] ASTAR, Inst Chem & Engn Sci, Singapore 627833, Singapore

[2] Natl Univ Singapore, Dept Chem & Biomol Engn, Singapore 117576, Singapore

来源：

CRYSTENGCOMM | 2009年 / 11卷 / 09期

关键词：

CO-CRYSTAL; 2,5-DIHYDROXYBENZOIC ACID; GENTISIC ACID; SOLVENT; POLYMORPH; CARBAMAZEPINE; TRANSFORMATION; ETHENZAMIDE; DISSOLUTION; IMPROVE;

D O I：

10.1039/b904616j

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

The first example of a trimorphic cocrystal involving two active pharmaceutical ingredients (APIs), ethenzamide and gentisic acid, is reported; metastable polymorphs convert to the stable form upon solid-state grinding; pharmaceutical cocrystals involving two or more APIs have potential relevance to combination drugs.

引用

页码：1823 / 1827

页数：5

共 51 条

[1] L-PROLINE 2,5-DIHYDROXYBENZOIC ACID (1/1) - A ZWITTERION CO-CRYSTAL [J].

AAKEROY, CB ;

BAHRA, GS ;

BROWN, CR ;

HITCHCOCK, PB ;

PATELL, Y ;

SEDDON, KR .

ACTA CHEMICA SCANDINAVICA, 1995, 49 (10) :762-767

[2] Do polymorphic compounds make good cocrystallizing agents?: A structural case study that demonstrates the importance of synthon flexibility [J].

Aakeröy, CB ;

Beatty, AM ;

Helfrich, BA ;

Nieuwenhuyzen, M .

CRYSTAL GROWTH & DESIGN, 2003, 3 (02) :159-165

[3] Concomitant polymorphs of 2,2′,6,6′-tetramethyl-4,4′-terphenyldiol:: the β-quinol network reproduced in a metastable polymorph [J].

Aitipamula, S ;

Nangia, A .

CHEMICAL COMMUNICATIONS, 2005, (25) :3159-3161

[4] Dimorphs of a 1:1 cocrystal of ethenzamide and saccharin: solid-state grinding methods result in metastable polymorph [J].

Aitipamula, Srinivasulu ;

Chow, Pui Shan ;

Tan, Reginald B. H. .

CRYSTENGCOMM, 2009, 11 (05) :889-895

[5] Crystal engineering of the composition of pharmaceutical phases.: Do pharmaceutical co-crystals represent a new path to improved medicines? [J].

Almarsson, Ö ;

Zaworotko, MJ .

CHEMICAL COMMUNICATIONS, 2004, (17) :1889-1896

[6] Designing Co-Crystals of Pharmaceutically Relevant Compounds That Crystallize with Z′ > 1 [J].

Anderson, Kirsty M. ;

Probert, Michael R. ;

Whiteley, Christopher N. ;

Rowland, Adrian M. ;

Goeta, Andres E. ;

Steed, Jonathan W. .

CRYSTAL GROWTH & DESIGN, 2009, 9 (02) :1082-1087

[7]

[Anonymous], 1997, SHELXL 97 SHELXS 97

[8] The co-crystal approach to improve the exposure of a water-insoluble compound: AMG 517 sorbic acid co-crystal characterization and pharmacokinetics [J].

Bak, Annette ;

Gore, Anu ;

Yanez, Evelyn ;

Stanton, Mary ;

Tufekcic, Sunita ;

Syed, Rashid ;

Akrami, Anna ;

Rose, Mark ;

Surapaneni, Sekhar ;

Bostick, Tracy ;

King, Anthony ;

Neervannan, Sesha ;

Ostovic, Drazen ;

Koparkar, Arun .

JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 97 (09) :3942-3956

[9] What is syncrystallization? States of the pH indicator methyl red in crystals of phthalic acid [J].

Benedict, JB ;

Cohen, DE ;

Lovell, S ;

Rohl, AL ;

Kahr, B .

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2006, 128 (16) :5548-5559

[10]

Bernstein J., 2020, Polymorphism in molecular crystals 2e, Vvol. 30

← 1 2 3 4 5 6 →